NYBC Ventures Investor

New York Blood Center created NYBC Ventures to accelerate innovation in blood-related fields and cellular therapies and technology. The fund was established by New York Blood Center with a $50 million investment and a mission to improve patients' lives by advancing therapeutics, enabling platforms and technologies, and driving collaborations to expand NYBC's impact.

Technology: Biomarker Discovery & Validation
Industry: BioPharma AI
Founded Date: 2021-01-01
Investor Type: Donors
Headquarters: Boston,Massachusetts,United States,North America
Funding Status: private